Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.08 USD | +1.13% | +3.62% | +152.79% |
04-10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
03-18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+152.79% | 923M | |
+3.96% | 111B | |
+11.36% | 105B | |
-12.81% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.33% | 13.7B | |
+36.11% | 12.45B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Transcript : Arcutis Biotherapeutics, Inc., Q4 2023 Earnings Call, Feb 27, 2024